Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Overwhelming genetic heterogeneity and exhausting molecular diagnostic process in chronic and progressive ataxias: facing it up with an algorithm, a gene, a panel at a time

Abstract

Ataxias are one of the most frequent complaints in Neurogenetics units worldwide. Currently, more than 50 subtypes of spinocerebellar ataxias and more than 60 recessive ataxias are recognized. We conducted an 11-year prospective, observational, analytical study in order to estimate the frequency of pediatric and adult genetic ataxias in Argentina, to describe the phenotypes of this cohort and evaluate the diagnostic yield of the algorithm used in our unit. We included 334 ataxic patients. Our diagnostic approach was successful in one-third of the cohort. A final molecular diagnosis was reached in 113 subjects. This rate is significantly higher in the subgroup of patients with a positive family history, where the diagnostic yield increased to 55%. The most prevalent dominant and recessive ataxias in Argentina were SCA-2 (36% of dominant ataxias) and FA (62% of recessive ataxias), respectively. Next generation sequencing-based assays were diagnostic in the 65% of the patients requiring these tests. These results provide relevant epidemiological information, bringing a comprehensive knowledge of the most prevalent subtypes of genetic ataxias and their phenotypes in our territory and laying the groundwork for rationally implementing genetic diagnostic programs for these disorders in our country.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Jayadev S, Bird TD. Hereditary ataxias: overview. Genet Med. 2013;15:673–83.

    Article  CAS  Google Scholar 

  2. Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014;42:174–83.

    Article  Google Scholar 

  3. Klockgether T, Paulson H. Milestones in ataxia. Mov Disord. 2011;26:1134–41.

    Article  Google Scholar 

  4. Bird TD. Hereditary ataxia overview. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al., editors. Seattle, WA: GeneReviews((R)); 1993.

  5. Synofzik M, Nemeth AH. Recessive ataxias. Handb Clin Neurol. 2018;155:73–89.

    Article  Google Scholar 

  6. Soong BW, Morrison PJ. Spinocerebellar ataxias. Handb Clin Neurol. 2018;155:143–74.

    Article  Google Scholar 

  7. Rodriguez-Quiroga SA, Gonzalez-Moron D, Arakaki T, Garreto N, Kauffman MA. The broad phenotypic spectrum of SCA-3: hereditary spastic paraplegia. Medicina. 2013;73:552–4.

    PubMed  Google Scholar 

  8. Cordoba M, Rodriguez-Quiroga S, Gatto EM, Alurralde A, Kauffman MA. Ataxia plus myoclonus in a 23-year-old patient due to STUB1 mutations. Neurology. 2014;83:287–8.

    Article  Google Scholar 

  9. Perez Akly M, Alvarez F. Late onset Friedreich ataxia: clinical description of a family in Argentina. Medicina. 2013;73:457–60.

    PubMed  Google Scholar 

  10. Rossi M, Cesarini M, Gatto EM, Cammarota A, Merello M. A treatable rare cause of progressive ataxia and palatal tremor. Tremor Other Hyperkinet Mov. 2018;8:538.

    Google Scholar 

  11. Teive HAG, Meira AT, Camargo CHF, Munhoz RP. The geographic diversity of spinocerebellar ataxias (SCAs) in the Americas: a systematic review. Mov Disord Clin Pract. 2019;6:531–40.

    Article  Google Scholar 

  12. Rodriguez-Quiroga SA, Cordoba M, Gonzalez-Moron D, Medina N, Vega P, Dusefante CV, et al. Neurogenetics in Argentina: diagnostic yield in a personalized research based clinic. Genet Res. 2015;97:e10.

    Article  Google Scholar 

  13. Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20.

    Article  CAS  Google Scholar 

  14. Burk K, Sival DA. Scales for the clinical evaluation of cerebellar disorders. Handb Clin Neurol. 2018;154:329–39.

    Article  Google Scholar 

  15. Ciotti P, Di Maria E, Bellone E, Ajmar F, Mandich P. Triplet repeat primed PCR (TP PCR) in molecular diagnostic testing for Friedreich ataxia. J Mol Diagn. 2004;6:285–9.

    Article  CAS  Google Scholar 

  16. Cohen L, Manin A, Medina N, Rodriguez-Quiroga S, Gonzalez-Moron D, Rosales J, et al. Argentinian clinical genomics in a leukodystrophies and genetic leukoencephalopathies cohort: diagnostic yield in our first 9 years. Ann Hum Genet. 2020;84:11–28.

    Article  Google Scholar 

  17. Cordoba M, Rodriguez-Quiroga SA, Vega PA, Salinas V, Perez-Maturo J, Amartino H, et al. Whole exome sequencing in neurogenetic odysseys: an effective, cost- and time-saving diagnostic approach. PLoS ONE. 2018;13:e0191228.

    Article  CAS  Google Scholar 

  18. Li H.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv. 2013;1303.3997.

  19. Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, et al. From FastQ data to high confidence variant calls: the genome analysis toolkit best practices pipeline. Curr Protoc Bioinform. 2013;43:11.10.1–33.

    Article  Google Scholar 

  20. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.

    Article  CAS  Google Scholar 

  21. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.

    Article  Google Scholar 

  22. Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014;312:1880–7.

    Article  CAS  Google Scholar 

  23. Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, McDonald MT, et al. Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet. 2012;49:353–61.

    Article  CAS  Google Scholar 

  24. Shashi V, Schoch K, Spillmann R, Cope H, Tan QK, Walley N, et al. A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative. Genet Med. 2019;21:161–72.

    Article  CAS  Google Scholar 

  25. Brusco A, Gellera C, Cagnoli C, Saluto A, Castucci A, Michielotto C, et al. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol. 2004;61:727–33.

    Article  Google Scholar 

  26. Moseley ML, Benzow KA, Schut LJ, Bird TD, Gomez CM, Barkhaus PE, et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology. 1998;51:1666–71.

    Article  CAS  Google Scholar 

  27. Venkatesh SD, Kandasamy M, Moily NS, Vaidyanathan R, Kota LN, Adhikarla S, et al. Genetic testing for clinically suspected spinocerebellar ataxias: report from a tertiary referral centre in India. J Genet. 2018;97:219–24.

    Article  Google Scholar 

  28. Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010;9:885–94.

    Article  CAS  Google Scholar 

  29. Sequeiros J, Coutinho P. Epidemiology and clinical aspects of Machado-Joseph disease. Adv Neurol. 1993;61:139–53.

    PubMed  CAS  Google Scholar 

  30. Sequeiros J, Martins S, Silveira I. Epidemiology and population genetics of degenerative ataxias. Handb Clin Neurol. 2012;103:227–51.

    Article  Google Scholar 

  31. Teive HA, Munhoz RP, Arruda WO, Raskin S, Werneck LC, Ashizawa T. Spinocerebellar ataxia type 10—a review. Parkinsonism Relat Disord. 2011;17:655–61.

    Article  Google Scholar 

  32. Zortea M, Armani M, Pastorello E, Nunez GF, Lombardi S, Tonello S, et al. Prevalence of inherited ataxias in the province of Padua, Italy. Neuroepidemiology. 2004;23:275–80.

    Article  CAS  Google Scholar 

  33. Infante J, Combarros O, Volpini V, Corral J, Llorca J, Berciano J. Autosomal dominant cerebellar ataxias in Spain: molecular and clinical correlations, prevalence estimation and survival analysis. Acta Neurol Scand. 2005;111:391–9.

    Article  CAS  Google Scholar 

  34. Palau F, Espinos C. Autosomal recessive cerebellar ataxias. Orphanet J Rare Dis. 2006;1:47.

    Article  Google Scholar 

  35. Wallace SE, Bird TD. Molecular genetic testing for hereditary ataxia: what every neurologist should know. Neurol Clin Pract. 2018;8:27–32.

    Article  Google Scholar 

  36. Rodriguez-Labrada R, Velazquez-Perez L, Auburger G, Ziemann U, Canales-Ochoa N, Medrano-Montero J, et al. Spinocerebellar ataxia type 2: measures of saccade changes improve power for clinical trials. Mov Disord. 2016;31:570–8.

    Article  CAS  Google Scholar 

  37. Velazquez-Perez LC, Rodriguez-Labrada R, Fernandez-Ruiz J. Spinocerebellar ataxia type 2: clinicogenetic aspects, mechanistic insights, and management approaches. Front Neurol. 2017;8:472.

    Article  Google Scholar 

  38. Burk K, Fetter M, Abele M, Laccone F, Brice A, Dichgans J, et al. Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol. 1999;246:789–97.

    Article  CAS  Google Scholar 

  39. Nemeth AH, Kwasniewska AC, Lise S, Parolin Schnekenberg R, Becker EB, Bera KD, et al. Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a model. Brain. 2013;136:3106–18.

    Article  Google Scholar 

  40. Higashi M, Ozaki K, Hattori T, Ishii T, Soga K, Sato N, et al. A diagnostic decision tree for adult cerebellar ataxia based on pontine magnetic resonance imaging. J Neurol Sci. 2018;387:187–95.

    Article  Google Scholar 

  41. De Michele G, Galatolo D, Barghigiani M, Dello Iacovo D, Trovato R, Tessa A, et al. Spinocerebellar ataxia type 48: last but not least. Neurol Sci. 2020. https://doi.org/10.1007/s10072-020-04408-3. [Epub ahead of print].

Download references

Acknowledgements

We thank the patients and families for their support and collaboration.

Funding

This study was funded by a grant from the Ministry of Science and Technology of Argentina.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by LZ, JPM, and SRQ. The first draft of the paper was written by LZ and JPM and all authors commented on previous versions of the paper. All authors read and approved the final paper. LZ and JPM contributed equally and should be considered both first authors in this work, while SRQ, and MK contributed equally and should be considered both as the last authors.

Corresponding author

Correspondence to S. Rodríguez-Quiroga.

Ethics declarations

Conflict of interest

JPM and VS have received scholarship support from Argentinean National Science Council (CONICET). MK has received grant support from Ministry of Health of Buenos Aires City, Argentinean National Science Council (CONICET) and Argentinean Ministry of Science and Technology. He serves as Associate Editor of the journal Neurologia Argentina. The rest of the authors declare that they have no conflict of interest.

Ethics approval

This study was approved by the Institutional Ethics Committee of the Hospital J.M. Ramos Mejia of Buenos Aires, Argentina. All patients and parents provided written informed consent for genetic analyses and use of their anonymized data. All experiments and methods were carried out in accordance with the relevant guidelines and regulations of the Institutional Ethics Committee of the Hospital J.M. Ramos Mejia of Buenos Aires, Argentina. All clinical investigations have been conducted in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent for genetic analyses and use of their anonymized data was obtained from all individual participants and/or parents included in the study. Patients signed informed consent regarding publishing their data.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perez Maturo, J., Zavala, L., Vega, P. et al. Overwhelming genetic heterogeneity and exhausting molecular diagnostic process in chronic and progressive ataxias: facing it up with an algorithm, a gene, a panel at a time. J Hum Genet 65, 895–902 (2020). https://doi.org/10.1038/s10038-020-0785-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-020-0785-z

This article is cited by

Search

Quick links